The efficacy of percutaneous microwave ablation for limited liver metastases of nasopharyngeal carcinoma

唐　田; 古善智; 李国文

doi:10.19401/j.cnki.1007-3639.2016.11.011

您当前的位置：

首页 >

文章列表页 >

The efficacy of percutaneous microwave ablation for limited liver metastases of nasopharyngeal carcinoma

更新时间：2025-12-31

- The efficacy of percutaneous microwave ablation for limited liver metastases of nasopharyngeal carcinoma
- China Oncology Vol. 26, Issue 11, Pages: 943-946(2016)
- 作者机构：
  
  湖南省肿瘤医院，暨中南大学湘雅医学院附属肿瘤医院介入科,湖南,长沙,410013
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2016.11.011
  CLC：
- Published Online：22 January 2017，
  
  Published：22 January 2016
- 稿件说明：
移动端阅览
唐　田,古善智,李国文,等. 经皮微波消融治疗鼻咽癌局限肝转移的疗效分析[J]. 中国癌症杂志, 2016, 26(11): 943-946.

唐　田, 古善智, 李国文. The efficacy of percutaneous microwave ablation for limited liver metastases of nasopharyngeal carcinoma[J]. China Oncology, 2016, 26(11): 943-946.
唐　田,古善智,李国文,等. 经皮微波消融治疗鼻咽癌局限肝转移的疗效分析[J]. 中国癌症杂志, 2016, 26(11): 943-946. DOI： 10.19401/j.cnki.1007-3639.2016.11.011.

唐　田, 古善智, 李国文. The efficacy of percutaneous microwave ablation for limited liver metastases of nasopharyngeal carcinoma[J]. China Oncology, 2016, 26(11): 943-946. DOI： 10.19401/j.cnki.1007-3639.2016.11.011.

摘要

背景与目的：局限性肝转移瘤由于数目、大小可控，局部微创治疗可以有效提高患者的生存期，微波消融已经成为肝转移瘤的重要治疗手段。该研究旨在探讨经皮肝穿刺微波消融治疗局限性鼻咽癌肝转移瘤的应用价值。方法：收集湖南省肿瘤医院自2011年9月—2014年10月共26例晚期放化疗失败的鼻咽癌肝脏转移患者的临床资料。患者肿瘤病灶数目小于等于3个，直径小于等于5 cm，且无其他远处转移病灶。在B超引导下行经皮肝穿刺微波消融治疗，26例患者共完成43次消融治疗，术后1个月复查肝功能、增强CT或者MRI，在mRECIST标准评价肿瘤治疗疗效。观察患者术后并发症，统计患者无疾病进展时间(progression-free survival，PFS)及总生存期(overall survival，OS)。结果：26例患者共53个病灶，其中完全消融(complete ablation，CA)20例(20/26，77.0%)，部分消融(part ablation，PA)3例(3/26，11.5%)，整体有效率(CA+PA)为88.5%，无严重并发症出现，26例患者0.5、1和2年生存率分别为96.1%、65.3%和23.0%，PFS为11.4个月，中位生存期(median survival time，MST)为17.8个月，OS为23.7个月。结论：经皮肝穿刺微波消融治疗局限性鼻咽癌肝转移瘤是微创、安全、有效的治疗方法。

Abstract

Background and purpose: Since the number and tumor size of localized liver metastases can be controlled

local minimally invasive treatment can improve the survival of patients. Hence

microwave ablation has become an important treatment method for liver metastases. This study was to investigate the value of percutaneous microwave ablation in the treatment of tumor metastases. Methods: From Sep. 2011 to Oct. 2014

26 advanced nasopharyngeal carcinoma patients with post-chemotherapy consolidation

liver metastases were collected. All the patients with the number of tumor lesions less than 3

diameter less than 5 cm

no other distant metastases was excluded. The ultrasound-guided percutaneous microwave ablation was used for 26 patients. Finally

43 ablations were completed followed by liver function test

enhanced CT and MRI diagnosis 1 month later. mRECIST criteria was used to evaluate the efficacy of cancer treatment. Progression-free survival (PFS) and overall survival (OS) were calculated. Results: Twenty-six cases of a total of 53 lesions

including complete ablation (CA) 20 patients (20/26

77.0%)

partial ablation (PA) 3 patients (3/26

11.5%). The overall efficiency was 88.5% (CA + PA) with no serious complications. 6 months

2-year survival rates of 26 patients were 96.1%

65.3% and 23.0%. PFS was 11.4 months. The median survival time (MST) was 11.9 months

while OS was 23.7 months. Conclusion: Percutaneous microwave ablation for limited liver metastases of nasopharyngeal carcinoma is a minimally invasive

safe and effective treatment method.

关键词

Keywords

references

Views

2002

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The diagnostic value of zero echo time magnetic resonance imaging for skull base bone invasion in nasopharyngeal carcinoma

Microwave ablation versus hepatic resection in potentially resectable colorectal liver metastasis: a systematic review and meta-analysis

A comparative analysis of the long-term efficacy between partial hepatectomy and transcatheter arterial chemoembolization in patients with liver metastasis from nasopharyngeal carcinoma

Study on the mechanism of DDX6 promoting proliferation and migration of nasopharyngeal carcinoma cells by regulating stability of CKMT1A mRNA

Mechanism of circular RNA hsa_circ_0012779 expression in nasopharyngeal carcinoma and its influence on cell biological behavior

Related Author

Jiahao LIN

Meimei FENG

Kongqi LIN

Fengjie LIN

Yunbin CHEN

Zesong MENG

Baokun LI

Longfei CAO

Related Institution

Department of Radiation Oncology, Fujian Cancer Hospital, Clinical Oncology School of Fujian Medical University

Department of Radiology, Fujian Cancer Hospital, Clinical Oncology School of Fujian Medical University

Department of General Surgery, The Second Hospital of Hebei Medical University

The Second Department of General Surgery, The Fourth Hospital of Hebei Medical University

Department of Liver Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

AI问答

⁰